The authors demonstrate that the tumor‐intrinsic Setd2 deficiency enhances recruitment and reprogramming of neutrophils in pancreatic tumor, thereby escaping from immune surveillance via inhibiting the cytotoxicity of CD8+ T cells. The gene discussed is SETD2; the disease is pancreatic neoplasm.